Loma Receives Second Innobooster

June 2026:  Loma Therapeutics Receives Second Innobooster We are honored to have received a second Innobooster grant The grant totals 5.000.000 DKK (~€670.000), which will advance the development of Loma’s novel HPV-targeted immunotherapy that holds the...